Along with GSK and Pfizer, Sanofi and Boehringer Ingelheim GmbH have been sued by consumers. After the federal cases were ...
GSK Plc, Pfizer Inc. and other drugmakers must face trials in state court in Delaware after a judge found the evidence ...
As almost everyone knows, the manufacturers of COVID-19 vaccines are immune from lawsuits until later this year. In February ...
GSK’s shares fell sharply following a judge's decision to allow more than 70,000 lawsuits to proceed, alleging it’s Zantac ...
GSK shares have plunged after a ruling by a Delaware judge that will force the company to face trial by jury for its Zantac ...
Pfizer Inc (NYSE:PFE) released longer-term follow-up results from the Phase 3 CROWN trial evaluating Lorbrena (lorlatinib) ...
The decision of a Delaware judge on Friday to allow more than 75,000 Zantac lawsuits to go forward to jury trials has left four major drugmakers—GSK, Pfizer, Sanofi and Boehringer Ingelheim ...
Shares in British drugmaker GSK fell sharply Monday following a Delaware judge's decision to allow more than 70,000 lawsuits to proceed, alleging that its discontinued heartburn medication Zantac ...
A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.
Last month, Shore Capital analysts estimated that up to $30bn (£24bn) for litigation was already priced into GSK’s shares. Pharma giant GSK is in hot water as it faces a barrage of lawsuits ...